Company intelligence / Profile preview

Allotex

Huntington Beach, California, United Statesus.allotex.com ↗

Ownership: Private
Development stage: Commercial

Overview

Allotex develops ophthalmic biologics and device-based solutions for vision correction by implanting precisely-shaped human corneal allografts to treat presbyopia, hyperopia, and myopia. The approach creates a permanent, living contact lens or lens insert. Recent updates include new investment and expansion of production facilities

Therapeutic areas: Ophthalmology
Modalities: Biologic (specifically human corneal allograft)Device (ophthalmic implant)
Industry: Biotech

Beyond the preview

Go deeper on Allotex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allotex.

Explore the full profile